Rising overdose deaths: Ohio State experts to review FDA's opioids plan and provide 'actionable recommendations'
The US remains stuck in a rapidly growing opioid epidemic, as overdose deaths quintupled over the last two decades to a record number of American deaths last year — more than 107,000.
As part of efforts to slow those rising numbers, and earn his Senate confirmation, FDA commissioner Rob Califf committed to a major review of the agency’s opioid decision-making process, including labeling.
And while Califf said late last month that the FDA had initiated a review of what needs to change to better support the appropriate use of opioids, he announced yesterday in a series of tweets that experts at The Ohio State University “will provide actionable recommendations for FDA both within existing authorities and where additional authorities are needed.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
